NCT05827263
- Conditions
- Bites and Stings, Chemically-Induced Disorders, Craniomandibular Disorders, +9 more
- Locations
-
- MK Dental Studio Marijampolė, Lithuania
Clinical trial condition
Chemically-Induced Disorders
Explore clinical trials studying Chemically-Induced Disorders. Study availability and eligibility vary by location and protocol.
7,301 public trials
1,007 recruiting studies
Chemically-Induced Disorders trial results
NCT05060445
- Conditions
- Anxiety, Anxiety Disorders, Behavior, +6 more
- Locations
-
- Westhill University Mexico City, Mexico
NCT04314648
- Conditions
- Alcohol Use Disorder, Alcohol-Related Disorders, Alcoholism, +11 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
Completed
Fathering In Recovery
NCT04611542
- Conditions
- Chemically-Induced Disorders, Father-Child Relations, Fathers, +6 more
- Locations
-
- Oregon Research Behavioral Intervention Strategies, Inc. Eugene, Oregon, United States
NCT05075629
- Conditions
- Anxiety, Anxiety Disorders, Behavior, +6 more
- Locations
-
- Alejandro Hernández Posadas Mexico City, Mexico
NCT03290391
- Conditions
- Blood-Borne Infections, Chemically-Induced Disorders, Communicable Diseases, +16 more
- Locations
-
- First St. Petersburg Pavlov State Medical University Saint Petersburg, Russia
- City Addiction Hospital Saint Petersburg, Russia
NCT02616094
- Conditions
- Alcohol Dependence, Alcohol-Related Disorders, Alcoholism, +3 more
- Locations
-
- Yale Stress Center New Haven, Connecticut, United States
NCT02872467
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Pregnancy, +2 more
- Locations
-
- UNC School of Medicine, Medical School Wing D Chapel Hill, North Carolina, United States
NCT01018654
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Substance-Related Disorders, +1 more
- Locations
-
- University of Utah Salt Lake City, Utah, United States
NCT03530215
- Conditions
- Cancer, Cardiac Disease, Cardiotoxicity, +9 more
- Locations
-
- AP-HP, Pitié-Salpêtrière Hospital,Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM. Paris, France